|
|
´ëºÀ¿¤¿¡½º, ¿ÃÇØ´Â ³»½Ç ´ÙÁö±â |
±è»ç¶û ±âÀÚ |
2018-05-21 10:07 |
ÄÚ½º¸ÞÄ«ÄÚ¸®¾Æ, ¸ÅÃâ »ç»ó ÃÖ´ë Àü¸Á-¼öÀͼº°³¼±Àº Á¡ÁøÀû |
±è»ç¶û ±âÀÚ |
2018-05-21 10:02 |
¾¾Á¨, ´Ã¾î³ ¿¬±¸°³¹ßºñ, µ¹¾Æ¿Â ½ÅÁ¦Ç° |
¹Úº´¿ì ±âÀÚ |
2018-05-21 09:48 |
[Á¦¾à] 4¿ù Á¶Á¤ ÀÌÈÄ ºÒÈ®½Ç¼ºÀº Á¡ÁøÀûÀ¸·Î ÇؼҵǴ Áß |
¹Úº´¿ì ±âÀÚ |
2018-05-19 08:03 |
Á¦¾à¹ÙÀÌ¿À/Issue Comments(ASCOÃʷϹßÇ¥Á÷ÈÄ ³ØŸ»ç ÁÖ°¡Ç϶ôÀº °úµµÇÏ´Ù°í ÆÇ´Ü |
¹Úº´¿ì ±âÀÚ |
2018-05-18 10:32 |
¶óÀÎ |
Á¦¾à/¹ÙÀÌ¿À, ¿¬±¸°á°ú ÃÊ·ÏÀ» ÅëÇÑ 6¿ù ASCO Á¡°Ë |
¹Úº´¿ì ±âÀÚ |
2018-05-18 08:47 |
Á¦¾à»ê¾÷, 4¿ù ¿ø¿Üó¹æ +3.4% y-y, º¸Å彺 ¼ºÀå µÐÈ |
¹Úº´¿ì ±âÀÚ |
2018-05-18 08:06 |
´ë¿øÁ¦¾à, 1Q18 ½ÇÀû Review: ºÐ±â »ç»ó ÃÖ´ë ¿µ¾÷ÀÌÀÍ ´Þ¼º.. |
¹Úº´¿ì ±âÀÚ |
2018-05-18 07:56 |
À¯³ªÀÌƼµåÁ¦¾à, °³·®½Å¾à ±â¹Ý ÀÌÀͼºÀå ÀáÀç·Â ´ëºñ ÁÖ°¡ ÀúÆò°¡ |
¹Úº´¿ì ±âÀÚ |
2018-05-18 07:51 |
[ÁýÁߺм®] ASCO ÃÊ·ÏÁý °ø°³¿Í ÀÓ»óÀ̺¥Æ® ±â¾÷ Á¤º¸ |
¹Úº´¿ì ±âÀÚ |
2018-05-17 11:03 |
¶óÀÎ |
Ƽ¾¾¿¥»ý¸í°úÇÐ, ¼¼°èÃÖÃÊ ÆеåÇü Áø´ÜÅ°Æ®·Î ÄöÅÒ Á¡ÇÁ¸¦ ²Þ²Ù´Ù |
±è»ç¶û ±âÀÚ |
2018-05-17 09:29 |
SK Pharma Weekly(5/9~16) |
±è»ç¶û ±âÀÚ |
2018-05-17 09:19 |
ÇコÄɾî Daily(5/17)-½ÅÇѱÝÀ¶ÅõÀÚ |
¹Úº´¿ì ±âÀÚ |
2018-05-17 08:59 |
´ë¿õÁ¦¾à, FDA·ÎºÎÅÍÀÇ È£Àç¿Í ¾ÇÀç |
¹Úº´¿ì ±âÀÚ |
2018-05-17 08:57 |
´ë¿õÁ¦¾à, CRLÀÌ ³ªº¸Å¸ ½ÂÀο¡ ¹ÌÄ¡´Â ¿µÇâ |
±è»ç¶û ±âÀÚ |
2018-05-17 08:53 |
¶óÀÎ |
JW»ý¸í°úÇÐ, º¯ÇÔ ¾ø´Â ¼ºÀå ½ºÅ丮 |
±è»ç¶û ±âÀÚ |
2018-05-17 08:47 |
¾¾Á¨, ¾Æ½¬¿î ºñ¿ë ÅëÁ¦ |
±è»ç¶û ±âÀÚ |
2018-05-17 08:40 |
Çѽº¹ÙÀÌ¿À¸Þµå, ÀÚ¼¼È÷ º¸¾Æ¾ß À̻ڴ٠|
¹Úº´¿ì ±âÀÚ |
2018-05-17 08:32 |
´ëÇѾàÇ°, 1Q18 Review:+¿µ¾÷ÀÌÀÍ 20. 1% YoY |
±è»ç¶û ±âÀÚ |
2018-05-16 09:48 |
ÇコÄɾî Daily(5/16)-½ÅÇѱÝÀ¶ÅõÀÚ |
±è»ç¶û ±âÀÚ |
2018-05-16 09:39 |
|